gRNA Market to reach USD 2,303.70 Million by 2032, and grow at a CAGR of 19.61%.
A rise in genomic investment and increasing adoption of gene-editing technologies are the key factors promoting the development of the gRNA market. According to the most recent statistics provided by the NIH, federal investment in genomic research has increased significantly. In 2023, the NIH is planning to invest USD 2.3 billion in genomic studies which makes up a 15% increase from the data of the previous year. The growing number of research activities and development of new gene editing tools, including gRNA vital for the CRISPR-related processes, stimulates further market promotion.